News & Events

June 18, 2026

Press release | LabGenius Therapeutics and LG Chem Enter a Research Collaboration, Option and License Agreement to Develop an AI/ML-Designed Tumour-Targeting Antibody

Upcoming Events

Jun 22

BIO International

Jun 24

Cell Engager Therapeutics Summit

Jul 8

World Bispecific Europe Summit

May 11, 2024

Feature | LabGenius featured in BBC Click episode, ‘Combating Cancer’

April 30, 2024

Interview | James Field describes how LabGenius is using machine intelligence to design the next generation of multispecific antibodies

April 5, 2024

Publication | Applications and challenges in designing VHH-based bispecific antibodies: leveraging machine learning solutions

January 17, 2024

Podcast | T-Cell Engagers: The New Cancer Drug?

December 22, 2023

Blog | Q&A with Mohammad Akhlaq, Head of Automation at LabGenius

November 15, 2023

Feature | BBC News covers LabGenius and how it harnesses AI in the search for new medicines

November 9, 2023

Podcast | LabGenius’ CEO, James Field, discusses ML-enabled drug discovery with Patrick Short on the Genetics Podcast

October 19, 2023

Report | The Life Sciences Future50

September 27, 2023

Podcast | Leveraging Generative AI to Design Therapeutic Antibodies

September 18, 2023

Press release | LabGenius’ Research Collaboration with Sanofi Yields Positive Results

September 18, 2023

Article | Questions Every VC Needs to Ask About Every AI Startup’s Tech Stack

September 18, 2023

Article | Machine Learning Enhances Antibody Discovery: A Glimpse into LabGenius and Sanofi’s Collaborative Endeavour